Ryan Hartmaier Selected Research

Ryan Hartmaier Research Topics

Disease

9	Neoplasms (Cancer) 04/2024 - 09/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2021
5	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2011
3	Disease Progression 04/2024 - 01/2021
1	Adenocarcinoma of Lung 04/2024
1	Kidney Neoplasms (Kidney Cancer) 10/2023
1	Vomiting 01/2021
1	Nausea 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2009

Drug/Important Bio-Agent (IBA)

4	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2021
2	osimertinibIBA 04/2024 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2021
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2023 - 01/2021
2	Histones (Histone)IBA 01/2021 - 12/2015
2	Messenger RNA (mRNA)IBA 12/2015 - 11/2012
2	Tamoxifen FDA LinkGeneric 11/2012 - 06/2011
1	capivasertibIBA 04/2024
1	Circulating Tumor DNAIBA 11/2023
1	thiaclopridIBA 10/2023
1	durvalumabIBA 10/2023
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	lenvatinibIBA 01/2018
1	CytidineIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 09/2017
1	Everolimus FDA Link 09/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2017
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Aromatase InhibitorsIBA 12/2015
1	Estrogen ReceptorsIBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 11/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2012
1	Co-Repressor ProteinsIBA 11/2012
1	Protein Isoforms (Isoforms)IBA 06/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2011
1	interleukin-21 (interleukin 21)IBA 09/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2009
1	Tumor Viral Antigens (Large T Antigen)IBA 09/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2009
1	VaccinesIBA 09/2009
1	AntigensIBA 09/2009
1	gp100 Melanoma AntigenIBA 09/2009
1	Peptides (Polypeptides)IBA 09/2009

Therapy/Procedure

5	Therapeutics 09/2017 - 09/2009
1	Immunotherapy 09/2009